Antonis C. Fanouriakis

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications

Views on pregnancy and related concerns among women with systemic lupus erythematosus: A cross-sectional study.

Views on pregnancy and related concerns among women with systemic lupus erythematosus: A cross-sectional study.

Journal: Lupus
Published: September 04, 2026

Management of systemic lupus erythematosus with kidney involvement: systematic literature review to inform the 2025 update of EULAR recommendations.

Management of systemic lupus erythematosus with kidney involvement: systematic literature review to inform the 2025 update of EULAR recommendations.

Journal: EULAR rheumatology open
Published: June 29, 2026

Factors associated with clinically significant nephritis in systemic lupus erythematosus patients who present with glomerular hematuria: a cross-sectional study.

Factors associated with clinically significant nephritis in systemic lupus erythematosus patients who present with glomerular hematuria: a cross-sectional study.

Journal: Rheumatology international
Published: June 20, 2026

International development of a lupus-specific instrument to assess cognitive symptoms in patients with SLE: Lupus Brain Fog Severity Scale (LBFSS) study.

International development of a lupus-specific instrument to assess cognitive symptoms in patients with SLE: Lupus Brain Fog Severity Scale (LBFSS) study.

Journal: Lupus science & medicine
Published: May 07, 2026

Attainment of early targets does not ensure a complete response at 12 months in lupus nephritis, especially in nephrotic-range proteinuria.

Attainment of early targets does not ensure a complete response at 12 months in lupus nephritis, especially in nephrotic-range proteinuria.

Journal: Rheumatology (Oxford, England)
Published: April 23, 2026

The burden of steroid use in systemic lupus erythematosus.

The burden of steroid use in systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)
Published: March 31, 2026

Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?

Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?

Journal: Kidney international
Published: March 28, 2026

Clinical and Serological Characteristics of Idiopathic Inflammatory Myopathies According to the Presence of Interstitial Lung Disease and Initial Evaluating Medical Specialty: A Single-Center Experience.

Clinical and Serological Characteristics of Idiopathic Inflammatory Myopathies According to the Presence of Interstitial Lung Disease and Initial Evaluating Medical Specialty: A Single-Center Experience.

Journal: Journal of personalized medicine
Published: March 24, 2026

Development and validation of EULAR quality indicators for lupus nephritis: adherence trends and impact on clinical outcomes.

Development and validation of EULAR quality indicators for lupus nephritis: adherence trends and impact on clinical outcomes.

Journal: Annals of the rheumatic diseases
Published: March 11, 2026

No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort study.

No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort study.

Journal: RMD open
Published: March 10, 2026

Beyond renal response: sustained systemic disease control protects against adverse long-term outcomes in lupus nephritis.

Beyond renal response: sustained systemic disease control protects against adverse long-term outcomes in lupus nephritis.

Journal: Lupus science & medicine
Published: February 19, 2026

Carotid-femoral pulse wave velocity improves cardiovascular risk prediction beyond SCORE2 in autoimmune rheumatic diseases: a 7-year follow-up study.

Carotid-femoral pulse wave velocity improves cardiovascular risk prediction beyond SCORE2 in autoimmune rheumatic diseases: a 7-year follow-up study.

Journal: RMD open
Published: February 15, 2026
Showing 1-12 of 140

Last Updated: 09/26/2026